| Abstract | BACKGROUND: Tumour necrosis factor (TNF)-alpha inhibitors are a major advance in the management of inflammatory bowel disease but increase the risk for tuberculosis (TB). AIM: To examine the reasons for the increase in the risk for TB and the strategies to reduce it. METHODS: PubMed searches were performed using search terms that included TB and each of the current anti-TNF-alpha biological agents and also TB and Crohn's disease. RESULTS: Increased susceptibility to TB, often with extrapulmonary or disseminated disease, occurs following treatment with all anti-TNF-alpha biological agents and amounts to a four- to 20-fold increased risk with infliximab. TB usually occurs shortly after anti-TNF-alpha initiation suggesting reactivation of latent infection. Animal studies show that TNF-alpha inhibition impairs inflammatory cell trafficking and granuloma formation. Currently recommended screening for latent TB typically, risk assessment, tuberculin skin testing and chest radiograph used prior to anti-TNF-alpha treatment can reduce TB rates by up to 90% but newer screening interferon gamma assays may enhance screening efficacy. Patients positive on screening who are treated with isoniazid and subsequently receive anti-TNF-alpha treatment still have approximately 19% risk for TB. CONCLUSIONS: Tuberculosis following treatment with TNF-alpha inhibitors usually results from reactivation of latent disease. Screening reduces the risk substantially but does not completely eliminate it. |
| Authors | V S Theis, J M Rhodes
(Affiliation: University Hospital Aintree, Department of Gastroenterology, UK.)
|
| Journal | Alimentary pharmacology & therapeutics
(Aliment Pharmacol Ther)
Vol. 27
Issue 1
Pg. 19-30
(Jan 1 2008)
ISSN: 1365-2036 England |
| PMID | 17944997
(Publication Type: Journal Article, Review)
|
| Chemical References |
- Tumor Necrosis Factor-alpha
|
| Topics |
- Animals
- Humans
- Inflammatory Bowel Diseases
(drug therapy)
- Radiography, Thoracic
- Risk Assessment
- Tuberculin Test
- Tuberculosis
(chemically induced, diagnosis, prevention & control)
- Tumor Necrosis Factor-alpha
(antagonists & inhibitors)
|
